By Mabell, Dave on December 5, 2018.
One of Canada’s leading cancer researchers will speak to a Lethbridge audience this afternoon.
Gregg Morin will describe recent discoveries during a 2:30 p.m. presentation, open to all interested, in room C610 in University Hall.
The longtime head of proteomics at the Genome Sciences Centre at the University of British Columbia, Morin and his team have been examining the functional mechanisms of proteins linked to cancer cells. At the same time, they are focusing on their interaction with ribonucleic acid (RNA) which, along with the more widely known DNA (deoxyribonucleic acid) is found in all known forms of life.
“Dr. Morin’s research directly links our understanding of RNAs and proteins to the dysregulation of gene expression in cancer,” says Ute Kothe, a leading RNA researcher at U of L.
“We are looking forward to not only discussing our joint research interests with Dr. Morin, but also how we can address the pressing questions in cancer research together.”
Since the early 1990s, researchers say, the focus has been on the source of most cancers, the mutations in DNA. Those mutations can be carried forward to trigger mutations in the RNA that can lead to aberrations in the body’s regulatory processes, or to the production of mutated proteins.
Today’s no-charge presentation is part of a speaker series created by the Alberta RNA Research and Training Institute. In recognition of the series’ importance, this event has been sponsored by the International RNA Society as part of its goal of promoting more RNA-related research.
As a result of ongoing research, medical officials say, Canada’s cancer death rates – following diagnosis – have decreased since 1988 by 17 per cent in women and 32 per cent in men.
Follow @DMabellHertald on Twitter
You must be logged in to post a comment.